Cutting edge: Maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation

Journal of Immunology

Volumn 194, Issue 3, 2015, Pages 863-867

  Krishnamoorthy, Nandini ^a   Burkett, Patrick R ^a   Dalli, Jesmond ^b   Abdulnour, Raja Elie E ^a   Colas, Romain ^b   Ramon, Sesquile ^b,c   Phipps, Richard P ^c   Petasis, Nicos A ^d   Kuchroo, Vijay K ^a   Serhan, Charles N ^b   Levy, Bruce D ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; AMPHIREGULIN; CD11B ANTIGEN; CD19 ANTIGEN; CD45 ANTIGEN; CELL PROTEIN; DOCOSAHEXAENOIC ACID; GLYCOPROTEIN P 15095; INTERLEUKIN 13; INTERLEUKIN 5; MARESIN 1 PROTEIN; RETINOIC ACID; SMAD3 PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; 7,14-DIHYDROXYDOCOSA-4,8,10,12,16,19-HEXAENOIC ACID; CYTOKINE;

ADOPTIVE TRANSFER; ALLERGY; ANIMAL CELL; ARTICLE; ASTHMA; CD3+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; INNATE IMMUNITY; LIPIDOMICS; LUNG LAVAGE; METABOLOLIPIDOMICS; METABOLOMICS; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; HYPERSENSITIVITY; IMMUNITY, INNATE; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; PNEUMONIA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84921489456     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402534     Document Type: Article

References (20)

1. Lloyd, C. M., and E. M. Hessel. 2010. Functions of T cells in asthma: more than just T(H)2 cells. Nat. Rev. Immunol. 10: 838-848.
2. Halim, T. Y., C. A. Steer, L. Mathä, M. J. Gold, I. Martinez-Gonzalez, K. M. McNagny, A. N. McKenzie, and F. Takei. 2014. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40: 425-435.
3. Barlow, J. L., A. Bellosi, C. S. Hardman, L. F. Drynan, S. H. Wong, J. P. Cruickshank, and A. N. McKenzie. 2012. Innate IL-13-producing nuocytes arise during lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 129: 191-198.e1-4.
4. Bartemes, K. R., K. Iijima, T. Kobayashi, G. M. Kephart, A. N. McKenzie, and H. Kita. 2012. IL-33-responsive lineage-CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J. Immunol. 188: 1503-1513.
5. Spits, H., and J. P. Di Santo. 2011. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12: 21-27.
6. Di Santo, J. P. 2014. Staying innate: transcription factor maintenance of innate lymphoid cell identity. Immunol. Rev. 261: 169-176.
7. Serhan, C. N., R. Yang, K. Martinod, K. Kasuga, P. S. Pillai, T. F. Porter, S. F. Oh, and M. Spite. 2009. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 206: 15-23.
8. Sonnenberg, G. F., and D. Artis. 2012. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 37: 601-610.
9. Buckley, C. D., D. W. Gilroy, and C. N. Serhan. 2014. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 40: 315-327.
10. Barnig, C., M. Cernadas, S. Dutile, X. Liu, M. A. Perrella, S. Kazani, M. E. Wechsler, E. Israel, and B. D. Levy. 2013. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci. Transl. Med. 5: 174ra26.
11. Freedman, S. D., P. G. Blanco, M. M. Zaman, J. C. Shea, M. Ollero, I. K. Hopper, D. A. Weed, A. Gelrud, M. M. Regan, M. Laposata, et al. 2004. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N. Engl. J. Med. 350: 560-569.
12. Rogerio, A. P., O. Haworth, R. Croze, S. F. Oh, M. Uddin, T. Carlo, M. A. Pfeffer, R. Priluck, C. N. Serhan, and B. D. Levy. 2012. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J. Immunol. 189: 1983-1991.
13. Levy, B. D., P. Kohli, K. Gotlinger, O. Haworth, S. Hong, S. Kazani, E. Israel, K. J. Haley, and C. N. Serhan. 2007. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J. Immunol. 178: 496-502.
14. Dalli, J., M. Zhu, N. A. Vlasenko, B. Deng, J. Z. Haeggström, N. A. Petasis, and C. N. Serhan. 2013. The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype. FASEB J. 27: 2573-2583.
15. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
16. Monticelli, L. A., G. F. Sonnenberg, M. C. Abt, T. Alenghat, C. G. Ziegler, T. A. Doering, J. M. Angelosanto, B. J. Laidlaw, C. Y. Yang, T. Sathaliyawala, et al. 2011. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12: 1045-1054.
17. Turner, J. E., P. J. Morrison, C. Wilhelm, M. Wilson, H. Ahlfors, J. C. Renauld, U. Panzer, H. Helmby, and B. Stockinger. 2013. IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J. Exp. Med. 210: 2951-2965.
18. Nussbaum, J. C., S. J. Van Dyken, J. von Moltke, L. E. Cheng, A. Mohapatra, A. B. Molofsky, E. E. Thornton, M. F. Krummel, A. Chawla, H. E. Liang, and R. M. Locksley. 2013. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502: 245-248.
19. Yu, S., H. Y. Kim, Y. J. Chang, R. H. DeKruyff, and D. T. Umetsu. 2014. Innate lymphoid cells and asthma. J. Allergy Clin. Immunol. 133: 943-950, quiz 51.
20. Chen, W. 2013. Regulatory T cells use "Itch" to control asthma. J. Clin. Invest. 123: 4576-4578.